Recalls for Antipsychotic

Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter
08/02/2013 Medical Recall

Risk of thromboembolism, some life-threatening (such as pulmonary emboli), as well as other serious adverse events.

  • Company:
    Nexus Pharmaceuticals Inc.
Benztropine Mesylate Injection by Fresenius Kabi USA: Recall - Potential Presence Of Glass Particles
07/02/2013 Medical Recall

If present, the administration of glass particulate poses a potential safety risk to patients.

  • Company:
    Fresenius Kabi USA